0001209191-15-081517.txt : 20151120
0001209191-15-081517.hdr.sgml : 20151120
20151120160827
ACCESSION NUMBER: 0001209191-15-081517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151118
FILED AS OF DATE: 20151120
DATE AS OF CHANGE: 20151120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151246789
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-18
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-11-18
4
M
0
10400
35.64
A
355684
D
Common Stock
2015-11-18
4
S
0
2800
128.96
D
352884
D
Common Stock
2015-11-18
4
S
0
800
130.25
D
352084
D
Common Stock
2015-11-18
4
S
0
3100
131.55
D
348984
D
Common Stock
2015-11-18
4
S
0
3300
132.44
D
345684
D
Common Stock
2015-11-18
4
S
0
400
133.03
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-11-18
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
104800
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $128.96 (range $128.71 to $129.52).
Open market sales reported on this line occurred at a weighted average price of $130.25 (range $129.93 to $130.83).
Open market sales reported on this line occurred at a weighted average price of $131.55 (range $130.94 to $131.89).
Open market sales reported on this line occurred at a weighted average price of $132.44 (range $131.95 to $132.89).
Open market sales reported on this line occurred at a weighted average price of $133.03 (range $132.96 to $133.07).
Fully vested.
Omar White, Attorney-In-Fact
2015-11-20